Processor register

Perma-Fix Comments on Recently Published Department of Energy Notice

Retrieved on: 
Monday, February 6, 2023
Hanford Site, Processor register, Ecosystem, ROD, EIS, DOE, Federal Register, National Environmental Policy Act, National Environmental Engineering Research Institute, DSSI, TC, PESI, SA, U.S. Department of Energy, Office of Inspector General, WM, NEPA, Growth, Renewable energy

DOE also proposes to potentially dispose of some of these secondary wastes (after treatment) offsite at a licensed and permitted commercial disposal facility.

Key Points: 
  • DOE also proposes to potentially dispose of some of these secondary wastes (after treatment) offsite at a licensed and permitted commercial disposal facility.
  • This action would be implemented on an interim basis until such time as an enhanced onsite treatment capability is available for Direct-Feed Low-Activity Waste (DFLAW) operations (estimated to be approximately 10 years).
  • The volumes and waste types defined in this amendment reflect our core offering and represents a significant opportunity for growth in our backlog.
  • We remain committed to exceeding expectations by providing safe, commercial, waste processing to support the Hanford closure mission.”

SEC Proposes Rule to Prohibit Conflicts of Interest in Certain Securitizations

Retrieved on: 
Wednesday, January 25, 2023
Security (finance), Commission, Processor register, Dodd–Frank Wall Street Reform and Consumer Protection Act, Federal Register, Sale, ABS, Financial adviser, Insurance

The rule is intended to prevent the sale of asset-backed securities (ABS) that are tainted by material conflicts of interest.

Key Points: 
  • The rule is intended to prevent the sale of asset-backed securities (ABS) that are tainted by material conflicts of interest.
  • Specifically, the rule would prohibit securitization participants from engaging in certain transactions that could incentivize a securitization participant to structure an ABS in a way that would put the securitization participant's interests ahead of those of ABS investors.
  • “This re-proposed rule is designed to help address conflicts of interest arising with market participants taking positions against investors’ interests.
  • The proposed rule would provide certain exceptions for risk-mitigating hedging activities, bona fide market-making activities, and certain commitments by a securitization participant to provide liquidity for the relevant ABS.

Federal Trade Commission Extends Public Comment Period on Potential Updates to its Green Guides for the Use of Environmental Marketing Claims

Retrieved on: 
Wednesday, February 1, 2023
Federal Register, News, Processor register, Social media, Federal Trade Commission, Commission, Green guides, Federal Trade Commission Act of 1914, FTC, Use, Blog, Dietary supplement, Animal

On December 14, 2022, the Federal Trade Commission announced it is seeking public comments on potential updates and changes to the Green Guides for the Use of Environmental Claims.

Key Points: 
  • On December 14, 2022, the Federal Trade Commission announced it is seeking public comments on potential updates and changes to the Green Guides for the Use of Environmental Claims.
  • The Commission’s Green Guides help marketers avoid making environmental marketing claims that are unfair or deceptive under Section 5 of the FTC Act.
  • The Commission seeks to update the guides based on increasing consumer interest in buying environmentally friendly products.
  • At the request of several interested parties, the Commission has extended the public comment period for 60 days, until April 24, 2023.

Federal Trade Commission Extends Public Comment Period on Potential Updates to its Green Guides for the Use of Environmental Marketing Claims

Retrieved on: 
Wednesday, February 1, 2023
Federal Register, News, Processor register, Social media, Federal Trade Commission, Commission, Green guides, Federal Trade Commission Act of 1914, FTC, Use, Blog, Dietary supplement, Animal

On December 14, 2022, the Federal Trade Commission announced it is seeking public comments on potential updates and changes to the Green Guides for the Use of Environmental Claims.

Key Points: 
  • On December 14, 2022, the Federal Trade Commission announced it is seeking public comments on potential updates and changes to the Green Guides for the Use of Environmental Claims.
  • The Commission’s Green Guides help marketers avoid making environmental marketing claims that are unfair or deceptive under Section 5 of the FTC Act.
  • The Commission seeks to update the guides based on increasing consumer interest in buying environmentally friendly products.
  • At the request of several interested parties, the Commission has extended the public comment period for 60 days, until April 24, 2023.

FTC Announces 2023 Update of Size of Transaction Thresholds for Premerger Notification Filings and Interlocking Directorates

Retrieved on: 
Thursday, January 26, 2023
ACT, News, Social media, Labour, Commission, Clayton Antitrust Act of 1914, Processor register, Federal Trade Commission, Clayton, Omnibus spending bill, Federal Register, Department, File, Blog, New York State Department of Labor, HSR, Federal, Section 8, FTC, FEE, Health insurance, Pet, Fine chemical

Section 7A(a)(2) of the act requires the Commission to revise the jurisdictional thresholds annually, based on the change in gross national product.

Key Points: 
  • Section 7A(a)(2) of the act requires the Commission to revise the jurisdictional thresholds annually, based on the change in gross national product.
  • The FTC revises the filing fees annually based on the change in the U.S. consumer price index.
  • The 2023 Consolidated Appropriations Act requires the FTC to revise the HSR filing fee thresholds.
  • For the latest news and resources, follow the FTC on social media, subscribe to press releases and read our blog.

FTC Announces 2023 Update of Size of Transaction Thresholds for Premerger Notification Filings and Interlocking Directorates

Retrieved on: 
Thursday, January 26, 2023
ACT, News, Social media, Labour, Commission, Clayton Antitrust Act of 1914, Processor register, Federal Trade Commission, Clayton, Omnibus spending bill, Federal Register, Department, File, Blog, New York State Department of Labor, HSR, Federal, Section 8, FTC, FEE, Health insurance, Pet, Fine chemical

Section 7A(a)(2) of the act requires the Commission to revise the jurisdictional thresholds annually, based on the change in gross national product.

Key Points: 
  • Section 7A(a)(2) of the act requires the Commission to revise the jurisdictional thresholds annually, based on the change in gross national product.
  • The FTC revises the filing fees annually based on the change in the U.S. consumer price index.
  • The 2023 Consolidated Appropriations Act requires the FTC to revise the HSR filing fee thresholds.
  • For the latest news and resources, follow the FTC on social media, subscribe to press releases and read our blog.

EyePoint Pharmaceuticals Provides Business Update and Key 2023 Clinical Timelines

Retrieved on: 
Thursday, January 5, 2023
Clinical trial, CY, Therapy, Eye, Diabetic retinopathy, Inflammation, Federal, VEGF, CALM, Severe cognitive impairment, Cleveland, Disease, Centers for Medicare & Medicaid Services, Patient, Growth, Retina, AMD, TKI, Safety, ASC, Processor register, Investment, Cleveland Clinic, Toxic epidermal necrolysis, Visual acuity, The Final Rule, Observation, DME, Medicare, Pharmaceutical industry

WATERTOWN, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced a business update and key 2023 clinical timelines for its lead product candidate, EYP-1901.

Key Points: 
  • – Cash and investments of approximately $144 million as of December 31, 2022 –
    WATERTOWN, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, today announced a business update and key 2023 clinical timelines for its lead product candidate, EYP-1901.
  • EYP-1901 is currently in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD) and non-proliferative diabetic retinopathy (NPDR).
  • In addition, we initiated Phase 2 clinical trials in both wet AMD and NPDR,” said Nancy Lurker, Chief Executive Officer of EyePoint Pharmaceuticals.
  • Topline interim six-month data from the Phase 2 DAVIO 2 clinical trial for wet AMD is anticipated in 4Q 2023.